A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07

Summary

This is a Phase 1, Randomized, Placebo-Controlled, Modified Parallel Design Multiple Ascending Dose Study of NTRX 07 to Assess Safety and Tolerability and Pharmacokinetics in Adult Healthy Volunteers and Subjects with MCI or Early AD. In addition, an exploratory study of the effect of a high fat meal was conducted.

Timeline

Start

2022-09-06

Primary completion

2023-05-31

Completion

2023-06-30

Drugs

Indications